Behavioral Programs for Diabetes Mellitus

Table 12. Network meta-analysis for effect moderation on HbA 1c results in T2DM: description of nodes and results (continued)
Arm Description
Rank Order of Effect,
Method of Delivery Delivery MD (%HbA
Studies & Sample Size Intensity
1c), 95% Probability of
Communication Method Personnel Credibility Interval Being Best
of Study Arms
DSME + Support 8 210
≤10h In person Individual & NA -0.70 [-1.80, 0.40] 6.8% a
N = 90
mixed
34 152
≤10h In person Group only NA 2.83 [1.22, 4.43] 0.0%
N = 48
17 172,207,230
≤10h Some technology Individual & NA -0.38 [-0.99, 0.23] 0.0%
N = 334
mixed
14 164
11-26h In person Individual & NA -0.44 [-1.76, 0.86] 4.8% a
N = 52
mixed
6 150,208,209
11-26h In person Group only NA -0.74 [-1.56, 0.08] 2.8% a
N = 267
16 152,189,209,222
11-26h Some technology Individual & NA -0.39 [-1.06, 0.28] 0.1%
N = 240
mixed
10 216,217
≥27h In person Individual & NA -0.54 [-1.28, 0.20] 0.8% a
N = 197
mixed
4 150,151
≥27h In person Group only NA -0.88 [-1.86, 0.09] 9.4% a
N = 230
Lifestyle 32 145,188,249
≤10h In person Individual & NA 0.20 [-0.50, 0.92] 0.0%
N = 171
mixed
13 156,186
≤10h In person Group only NA -0.45 [-1.35, 0.45] 0.9% a
N = 44
33 188
≤10h Some technology Individual & NA 0.25 [-1.11, 1.62] 0.5%
N = 67
mixed
12 165,184,190,191,232,236 11-26h In person Individual & NA -0.47 [-0.99, 0.05] 0.0% a
N = 138
mixed
9 169,170,205,232,255
11-26h In person Group only NA -0.69 [-1.25, -0.12] 0.5% a
N = 161
3 143,160
11-26h Some technology Individual & NA -0.91 [-1.72, -0.10] 7.4% a
N = 76
mixed
23 254
11-26h Some technology Group only NA -0.20 [-1.28, 0.88] 0.9%
N = 74
2 137,161,174,214,261
≥27h In person Individual & NA -1.12 [-1.72, -0.53] 10.7% a
N = 233
mixed
30 239,240
≥27h In person Group only NA 0.07 [-0.67, 0.83] 0.0%
N = 305
18 166,252,262
≥27h Some technology Individual & NA -0.37 [-1.01, 0.27] 0.1%
N = 2643
mixed
DSME = diabetes self-management education; h = hour(s); HbA 1c = hemoglobin A 1c ; HCP = health care professional; MD = mean difference; NA = not applicable
a Highlighted rows represent those nodes having effect sizes meeting or exceeding our criteria for clinical importance.
65